Preliminary studies demonstrate that Retatrutide – a dual stimulator of GLP-1 and glucose-dependent insulinotropic polypeptide receptors – presents a substantial improvement in weight management therapies. In contrast to existing treatments , Retatrutide appears to influence hunger and metabolic